
SI-BONE Inc (SIBN) Stock Forecast & Price Target
SI-BONE Inc (SIBN) Analyst Ratings
Bulls say
SI-BONE is a promising investment due to its strong financial performance, strategic partnerships, and innovative products. They are poised for continued growth in the future, with plans to expand into new markets and product launches. However, there are potential risks such as reimbursement issues and competition, which should be closely monitored. With a specialized sales force and unique assets, the company remains a top pick for investors looking for high growth potential in the medical device industry.
Bears say
SI-BONE is facing potential headwinds in the near term, including potential downward pressure on average selling prices and the impact of proposed DRG changes. Additionally, the company's conservative revenue guidance may overlook potential catalysts, such as the potential contribution from the SNN partnership in 2H26 and the planned launch of a third novel implant system in 4Q26. While the company has a strong growth profile and a clear pathway to profitability, multiple compression within the industry may limit upside potential for the stock.
This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.
SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction
Start investing in SI-BONE Inc (SIBN)
Order type
Buy in
Order amount
Est. shares
0 shares